Home › NDC Lookup › RxCUI directory › RxCUI 2593376

Baclofen 5 MG/ML Oral Suspension — RxCUI 2593376

RxNorm drug concept · Semantic clinical drug
RxCUI 2593376 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2593376
Official nameBaclofen 5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbaclofen 25 MG per 5 ML Oral Suspension
FDA products mapped4
Package NDCs mapped7
Reported Medicaid activity (SDUD)36,372 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Baclofen: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Baclofen is prescribed to reduce spasticity — the muscle stiffness, spasms, and rigidity that come with conditions like multiple sclerosis or spinal cord injury. Oral forms are als...
  • What exactly is baclofen being used to treat — and will it help my pain too?
  • Yes, and this is really important. Stopping baclofen suddenly — especially the pump form — can cause a dangerous withdrawal reaction: your spasticity can return much worse than bef...
  • I heard you can't just stop taking baclofen — is that really true?
📖 Read our full Baclofen guide →

🕸️ Concept Web — How Baclofen 5 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Baclofen 5 MG/ML Oral Suspension RxCUI 2593376

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Baclofen 1292
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fleqsuvy 2593377
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Baclofen Oral Suspension 2593375
    • Baclofen Oral Liquid Product 1155669
    • Baclofen Oral Product 1155670
    • Baclofen Oral Suspension [Fleqsuvy] 2593381
    • Fleqsuvy Oral Liquid Product 2593380
    • Fleqsuvy Oral Product 2593379
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Baclofen 5 MG/ML SCDC · 2593374
  • Baclofen Oral Suspension SCDF · 2593375
  • Baclofen Oral Liquid Product SCDG · 1155669
  • Baclofen Oral Product SCDG · 1155670

Brand-Name Concepts

  • Baclofen 5 MG/ML Oral Suspension [Fleqsuvy] SBD · 2593382
  • Baclofen 5 MG/ML [Fleqsuvy] SBDC · 2593378
  • Baclofen Oral Suspension [Fleqsuvy] SBDF · 2593381
  • Fleqsuvy Oral Liquid Product SBDG · 2593380
  • Fleqsuvy Oral Product SBDG · 2593379
  • Fleqsuvy BN · 2593377

📦 FDA Products & Package NDCs

4 products · 7 package NDCs
7 package NDCs map to RxCUI 2593376 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52536-0600-11 1 BOTTLE in 1 CARTON (52536-600-11) / 120 mL in 1 BOTTLE Baclofen Wilshire Pharmaceuticals, Inc. 2023-04-01
52536-0600-12 1 BOTTLE in 1 CARTON (52536-600-12) / 300 mL in 1 BOTTLE Baclofen Wilshire Pharmaceuticals, Inc. 2023-04-01
52652-6001-01 1 BOTTLE in 1 CARTON (52652-6001-1) / 120 mL in 1 BOTTLE FLEQSUVY Azurity Pharmaceuticals, Inc. 2022-02-07
52652-6001-02 1 BOTTLE in 1 CARTON (52652-6001-2) / 300 mL in 1 BOTTLE FLEQSUVY Azurity Pharmaceuticals, Inc. 2022-02-07
62559-0204-03 1 BOTTLE in 1 CARTON (62559-204-03) / 300 mL in 1 BOTTLE Baclofen ANI Pharmaceuticals, Inc. 2024-03-19
62559-0204-12 1 BOTTLE in 1 CARTON (62559-204-12) / 120 mL in 1 BOTTLE Baclofen ANI Pharmaceuticals, Inc. 2024-03-18
71225-0140-01 1 BOTTLE in 1 CARTON (71225-140-01) / 250 mL in 1 BOTTLE BACLOFEN Slayback Pharma LLC 2023-06-19
Observed labelers: ANI Pharmaceuticals, Inc. (2) · Azurity Pharmaceuticals, Inc. (2) · Wilshire Pharmaceuticals, Inc. (2) · Slayback Pharma LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$3.7360
Range $3.5265–$5.9371 · middle 50% $3.5788–$5.3854 · 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.